Exact Mass: 560.2477464

Exact Mass Matches: 560.2477464

Found 500 metabolites which its exact mass value is equals to given mass value 560.2477464, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Labriformidin

C29H36O11 (560.2257506)

Chloramphenicol palmitate

2-[(Dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl palmitate

C27H42Cl2N2O6 (560.2419772000001)

C254 - Anti-Infective Agent > C258 - Antibiotic Same as: D01072

[L-Asp(4-L-Arg)]n+1

C20H36N10O9 (560.2666606)

Isomorellic acid

(2Z)-4-[12-hydroxy-8,8,21,21-tetramethyl-5-(3-methylbut-2-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0^{2,15}.0^{2,19}.0^{4,13}.0^{6,11}]docosa-4,6(11),9,12,15-pentaen-19-yl]-2-methylbut-2-enoic acid

C33H36O8 (560.2410056)

Morellic acid is found in fruits. Morellic acid is from Garcinia morella (batuan Isomorellic acid is a member of pyranoxanthones. Morellic acid is isolated from Garcinia Morella with an antiangiogenic activity[1]. Morellic acid is isolated from Garcinia Morella with an antiangiogenic activity[1].

Chloramphenicol palmitate

2-(2,2-dichloroacetamido)-3-hydroxy-3-(4-nitrophenyl)propyl hexadecanoate

C27H42Cl2N2O6 (560.2419772000001)

Sotorasib

6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-4-[(2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl]-1H,2H-pyrido[2,3-d]pyrimidin-2-one

C30H30F2N6O3 (560.2347334)

D000970 - Antineoplastic Agents > D000074322 - Antineoplastic Agents, Immunological > D000082082 - Immune Checkpoint Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1902 - Ras Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor Sotorasib (AMG-510) is a first-in-class, orally bioavailable, and selective KRAS G12C covalent inhibitor. Sotorasib irreversibly inhibits KRAS G12C by locking it in an inactive GDP-bound state. Sotorasib is the first KRAS G12C inhibitor in clinical development and leads to the regression of KRAS G12C tumors[1][2]. Sotorasib racemate (Compound A) is an orally active racemate of Sotorasib (HY-114277), a covalent inhibitor of KRAS G12C mutant which induces adaptive feedback activation of MAPK pathway. Sotorasib racemate also exerts inhibitor activity against KRAS G12C induced cancer and can be applied to cancer research[1].

1,2-Dehydrotelobine

(+)-1,2-Dehydrotelobine

C35H32N2O5 (560.2311102)

Jatamanvaltrate I

C29H36O11 (560.2257506)

Lancifodilactone E

(+)-Lancifodilactone E

Lancifodilactone L

cauferoside

C30H40O10 (560.2621340000001)

A natural product found in Ferula gumosa and Ferula conocaula.

citreohybridone J

C30H40O10 (560.2621340000001)

chlorahololide A

C33H36O8 (560.2410056)

Conferoside

C30H40O10 (560.2621340000001)

Tyr His Ile Glu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]pentanedioic acid

C26H36N6O8 (560.2594496)

Gln Asp Gly Asp Leu

C22H36N6O11 (560.2441946)

C36H36N2O4 (560.2674936)

phenylmercuric oleate

C24H38HgO2 (560.2577967999999)

3,3-(3,7,12,17-Tetramethyl-8,13-divinyl-2,18-porphyrindiyl)dipro panoate

C34H32N4O4 (560.2423431999999)

N-s-butyl-N-[(2R,3S)-3-({[(3aS,5R,6aR)-hexahydro-2H-cyclopenta[b]furan-5-yloxy]carbonyl}amino)-2-hydroxy-4-phenylbutyl]-4-(hydroxymethyl)benzenesulfonamide

C29H40N2O7S (560.255609)

3-[(3-Sec-butyl-4-hydroxybenzoyl)amino]azepan-4-YL 4-(2-hydroxy-5-methoxybenzoyl)benzoate

C32H36N2O7 (560.2522386)

n-1,2,3,4-Tetrahydronaphth-1-yl-2-[3,5-dimethoxybenzamido]-2-deoxy-adenosine

C29H32N6O6 (560.2383212)

Protoporphyrin(2-)

C34H32N4O4-2 (560.2423431999999)

Protoporphyrinate

C34H32N4O4-2 (560.2423431999999)

D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents COVID info from COVID-19 Disease Map D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Gumoside B

C30H40O10 (560.2621340000001)

C30H30F2N6O3 (560.2347334)

A pyridopyrimidine that is pyrido[2,3-d]pyrimidin-2(1H)-one substituted by 4-methyl-2-(propan-2-yl)pyridin-3-yl, (2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl, fluoro and 2-fluoro-6-hydroxyphenyl groups at positions 1, 4, 6 and 7, respectively. It is approved for the treatment of patients with non-small cell lung cancer having KRAS(G12C) mutations. D000970 - Antineoplastic Agents > D000074322 - Antineoplastic Agents, Immunological > D000082082 - Immune Checkpoint Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1902 - Ras Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor Sotorasib (AMG-510) is a first-in-class, orally bioavailable, and selective KRAS G12C covalent inhibitor. Sotorasib irreversibly inhibits KRAS G12C by locking it in an inactive GDP-bound state. Sotorasib is the first KRAS G12C inhibitor in clinical development and leads to the regression of KRAS G12C tumors[1][2]. Sotorasib racemate (Compound A) is an orally active racemate of Sotorasib (HY-114277), a covalent inhibitor of KRAS G12C mutant which induces adaptive feedback activation of MAPK pathway. Sotorasib racemate also exerts inhibitor activity against KRAS G12C induced cancer and can be applied to cancer research[1].

Protoporphyrin(2-)

C34H32N4O4 (560.2423431999999)

The dicarboxylate anion of protoporphyrin, obtained by deprotonation of both carboxy groups.

Protoporphyrinate

C34H32N4O4 (560.2423431999999)

MGDG 10:4_11:4

C30H40O10 (560.2621340000001)

LPG 20:6;O2

C26H41O11P (560.2386366)

ST 20:1;O7;GlcA

C26H40O13 (560.246879)

ST 24:5;O4;GlcA

C30H40O10 (560.2621340000001)

ST 20:2;O8;Hex

C26H40O13 (560.246879)

ST 26:3;O8;S

C26H40O11S (560.2291210000001)

ST 27:2;O7;S

C27H44O10S (560.2655044)

9-hydroxy-9-({[2-(hydroxymethyl)-3-(5-isopropyl-3-oxo-4,5,6,7-tetrahydro-1h-2-benzofuran-4-yl)prop-2-enoyl]oxy}methyl)-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid

C30H40O10 (560.2621340000001)

(1r,3as,3bs,7r,9as,9bs,11ar)-3a-hydroxy-11a-methyl-1-(6-oxopyran-3-yl)-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-9a-carbaldehyde

(1r,3as,3bs,7r,9as,9bs,11ar)-3a-hydroxy-11a-methyl-1-(6-oxopyran-3-yl)-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C30H40O10 (560.2621340000001)

C27H44O10S (560.2655044)

{"Ingredient_id": "HBIN017151","Ingredient_name": "aspidistrogenin a","Alias": "NA","Ingredient_formula": "C27H44O10S","Ingredient_Smile": "CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6(C5(C(C(C(C6O)O)OS(=O)(=O)O)O)C)O)C)C)OC1","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1899","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

13,27-dimethoxy-22-methyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1,3,7,10,12,14(37),16,18,25(33),26,28(32),30(34),35-tridecaene

13,27-dimethoxy-22-methyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1,3,7,10,12,14(37),16,18,25(33),26,28(32),30(34),35-tridecaene

C35H32N2O5 (560.2311102)

(3r,5s,7r,9r,10s,12r,14r,15r,17s,18s,19r,22s,23s)-10,17,22-trihydroxy-9-methoxy-7,14,18-trimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1-en-16-one

(3r,5s,7r,9r,10s,12r,14r,15r,17s,18s,19r,22s,23s)-10,17,22-trihydroxy-9-methoxy-7,14,18-trimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1-en-16-one

C30H40O10 (560.2621340000001)

3-hydroxy-2-[(1-hydroxy-2,14-dimethyl-15-{5-methyl-2-[2-(1h-pyrrol-2-yl)ethenyl]-4,5-dihydro-1,3-oxazol-4-yl}pentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene)amino]-3-(c-hydroxycarbonimidoyl)propanoic acid

3-hydroxy-2-[(1-hydroxy-2,14-dimethyl-15-{5-methyl-2-[2-(1h-pyrrol-2-yl)ethenyl]-4,5-dihydro-1,3-oxazol-4-yl}pentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene)amino]-3-(c-hydroxycarbonimidoyl)propanoic acid

C31H36N4O6 (560.2634716)

(2e)-4-[(1r,2s,17s)-12-hydroxy-8,8,21,21-tetramethyl-5-(3-methylbut-2-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enoic acid

C32H36N2O7 (560.2522386)

methyl 13-ethylidene-8-methyl-18-(3,4,5-trimethoxybenzoyloxy)-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-triene-17-carboxylate

C32H36N2O7 (560.2522386)

(3s,3ar,4s,9s,11as)-4-{[(2r,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-hydroxy-3,6,10-trimethyl-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one

(3s,3ar,4s,9s,11as)-4-{[(2r,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-hydroxy-3,6,10-trimethyl-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one

C26H40O13 (560.246879)

4-({4-hydroxy-2-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxyphenyl}methyl)-3-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-5-methoxyphenol

C33H36O8 (560.2410056)

10,16,22-trihydroxy-9-methoxy-7,14,18-trimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1-en-17-one

C30H40O10 (560.2621340000001)

(3e,5s)-3-[(2e,4e,6e)-1-hydroxy-7-[(1s,6s)-6-[(1e,3e,5e)-7-hydroxy-7-[(3z,5s)-5-(hydroxymethyl)-2-methylidene-4-oxopyrrolidin-3-ylidene]hepta-1,3,5-trien-1-yl]cyclohex-2-en-1-yl]hepta-2,4,6-trien-1-ylidene]-5-(hydroxymethyl)-1-methylpyrrolidine-2,4-dione

(3e,5s)-3-[(2e,4e,6e)-1-hydroxy-7-[(1s,6s)-6-[(1e,3e,5e)-7-hydroxy-7-[(3z,5s)-5-(hydroxymethyl)-2-methylidene-4-oxopyrrolidin-3-ylidene]hepta-1,3,5-trien-1-yl]cyclohex-2-en-1-yl]hepta-2,4,6-trien-1-ylidene]-5-(hydroxymethyl)-1-methylpyrrolidine-2,4-dione

C32H36N2O7 (560.2522386)

(2s,6r)-2-{[(1r,3as,3br,5ar,7r,8r,9as,9bs,11s,11as)-3a,8,11-trihydroxy-9a,11a-dimethyl-10-oxo-1-(5-oxo-2h-furan-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

(2s,6r)-2-{[(1r,3as,3br,5ar,7r,8r,9as,9bs,11s,11as)-3a,8,11-trihydroxy-9a,11a-dimethyl-10-oxo-1-(5-oxo-2h-furan-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

C30H40O10 (560.2621340000001)

(3s,3ar,4s,9r,11ar)-4-{[(2r,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-hydroxy-3,6,10-trimethyl-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one

(3s,3ar,4s,9r,11ar)-4-{[(2r,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-hydroxy-3,6,10-trimethyl-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one

C26H40O13 (560.246879)

3-hydroxy-2-{[(2e,4e,6e,8e,10e,12e,14e)-1-hydroxy-2,14-dimethyl-15-[(4r,5r)-5-methyl-2-[(1e)-2-(1h-pyrrol-2-yl)ethenyl]-4,5-dihydro-1,3-oxazol-4-yl]pentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene]amino}-3-(c-hydroxycarbonimidoyl)propanoic acid

3-hydroxy-2-{[(2e,4e,6e,8e,10e,12e,14e)-1-hydroxy-2,14-dimethyl-15-[(4r,5r)-5-methyl-2-[(1e)-2-(1h-pyrrol-2-yl)ethenyl]-4,5-dihydro-1,3-oxazol-4-yl]pentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene]amino}-3-(c-hydroxycarbonimidoyl)propanoic acid

7-[(3,4-dihydroxy-6-methyloxan-2-yl)oxy]-3a,5a-dihydroxy-11a-methyl-11-oxo-1-(6-oxopyran-3-yl)-dodecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

C30H40O10 (560.2621340000001)

(5as,6r,9s,9as)-9-hydroxy-9-({[2-(hydroxymethyl)-3-[(4s,5r)-5-isopropyl-3-oxo-4,5,6,7-tetrahydro-1h-2-benzofuran-4-yl]prop-2-enoyl]oxy}methyl)-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid

(5as,6r,9s,9as)-9-hydroxy-9-({[2-(hydroxymethyl)-3-[(4s,5r)-5-isopropyl-3-oxo-4,5,6,7-tetrahydro-1h-2-benzofuran-4-yl]prop-2-enoyl]oxy}methyl)-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid

C30H40O10 (560.2621340000001)

4-[12-hydroxy-8,8,21,21-tetramethyl-5-(3-methylbut-2-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enoic acid

4-[12-hydroxy-8,8,21,21-tetramethyl-5-(3-methylbut-2-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enoic acid

C33H36O8 (560.2410056)

(3r,5s,7r,9r,10s,12r,14r,15s,16s,18r,19r,22s,23r)-10,16,22-trihydroxy-9-methoxy-7,14,18-trimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1-en-17-one

(3r,5s,7r,9r,10s,12r,14r,15s,16s,18r,19r,22s,23r)-10,16,22-trihydroxy-9-methoxy-7,14,18-trimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1-en-17-one

C30H40O10 (560.2621340000001)

(1r,3as,3br,7s,9as,9bs,10r,11ar)-3a,10-dihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-9a-carbaldehyde

(1r,3as,3br,7s,9as,9bs,10r,11ar)-3a,10-dihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-9a-carbaldehyde

(1ar,3r,3ar,4r,5r,6r,7as)-5-(acetyloxy)-6-[(1s,6r)-6-(2-methoxy-2-oxoethyl)-1,5,5-trimethyl-4-oxocyclohex-2-en-1-yl]-3a-methyl-7-methylidene-4-[(2-methylpropanoyl)oxy]-hexahydroindeno[1,7a-b]oxirene-3-carboxylic acid

(1ar,3r,3ar,4r,5r,6r,7as)-5-(acetyloxy)-6-[(1s,6r)-6-(2-methoxy-2-oxoethyl)-1,5,5-trimethyl-4-oxocyclohex-2-en-1-yl]-3a-methyl-7-methylidene-4-[(2-methylpropanoyl)oxy]-hexahydroindeno[1,7a-b]oxirene-3-carboxylic acid

C30H40O10 (560.2621340000001)

2-({4-hydroxy-2-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxyphenyl}methyl)-5-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-methoxyphenol

C33H36O8 (560.2410056)

(1s,3ar,3br,5as,7s,9ar,9bs,11ar)-3a-hydroxy-11a-methyl-1-(6-oxopyran-3-yl)-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-9a-carbaldehyde

(1s,3ar,3br,5as,7s,9ar,9bs,11ar)-3a-hydroxy-11a-methyl-1-(6-oxopyran-3-yl)-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C30H40O10 (560.2621340000001)

methyl (1r,9s,10s,12s,13z,16s,17s)-13-ethylidene-8-methyl-18-(3,4,5-trimethoxybenzoyloxy)-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-triene-17-carboxylate

C32H36N2O7 (560.2522386)

3a-hydroxy-11a-methyl-1-(6-oxopyran-3-yl)-5a-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C30H40O10 (560.2621340000001)

3a-hydroxy-11a-methyl-1-(6-oxopyran-3-yl)-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C30H40O10 (560.2621340000001)

(1s,2r,4ar,5r,8r,8ar)-2-(acetyloxy)-8a-hydroxy-3,8-dimethyl-5-(prop-1-en-2-yl)-2,4a,5,6,7,8-hexahydro-1h-naphthalen-1-yl (2r,4s,6r)-10-chloro-2-hydroxy-8-methyl-7-oxa-5,8-diazatricyclo[7.4.0.0²,⁶]trideca-1(13),9,11-triene-4-carboxylate

(1s,2r,4ar,5r,8r,8ar)-2-(acetyloxy)-8a-hydroxy-3,8-dimethyl-5-(prop-1-en-2-yl)-2,4a,5,6,7,8-hexahydro-1h-naphthalen-1-yl (2r,4s,6r)-10-chloro-2-hydroxy-8-methyl-7-oxa-5,8-diazatricyclo[7.4.0.0²,⁶]trideca-1(13),9,11-triene-4-carboxylate

C29H37ClN2O7 (560.2289162)

(2s,4as,4br,5r,6r,6ar,10ar,10br,12ar)-5-(acetyloxy)-2,4b,7,7,10a,12a-hexamethyl-1,4,8,12-tetraoxo-2-propanoyl-octahydrophenanthro[1,2-c]pyran-6-yl acetate

C30H40O10 (560.2621340000001)

(2z)-4-[(1s,2s,17s,19r)-12-hydroxy-8,8,21,21-tetramethyl-5-(3-methylbut-2-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enoic acid

(2z)-4-[(1s,2s,17s,19r)-12-hydroxy-8,8,21,21-tetramethyl-5-(3-methylbut-2-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enoic acid

C33H36O8 (560.2410056)

(5as,6r,9s,9as)-9-hydroxy-9-({[(2e)-2-(hydroxymethyl)-3-[(4s,5r)-5-isopropyl-3-oxo-4,5,6,7-tetrahydro-1h-2-benzofuran-4-yl]prop-2-enoyl]oxy}methyl)-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid

(5as,6r,9s,9as)-9-hydroxy-9-({[(2e)-2-(hydroxymethyl)-3-[(4s,5r)-5-isopropyl-3-oxo-4,5,6,7-tetrahydro-1h-2-benzofuran-4-yl]prop-2-enoyl]oxy}methyl)-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid

(3r,5s,7r,9s,10s,12r,14r,15s,17s,18s,19r,22s,23r)-10,17,22-trihydroxy-9-methoxy-7,14,18-trimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1-en-16-one

C30H40O10 (560.2621340000001)

2-{[3a,8,11-trihydroxy-9a,11a-dimethyl-10-oxo-1-(5-oxo-2h-furan-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

C30H40O10 (560.2621340000001)